Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Revolution Medicines, Inc.
Janssen Research & Development, LLC
Varian, a Siemens Healthineers Company
Verastem, Inc.
Boehringer Ingelheim
Bayer
Merck Sharp & Dohme LLC
Replimune Inc.
Intima Bioscience, Inc.
Carevive Systems, Inc.
Pilatus Biosciences Inc
Amgen
GlaxoSmithKline
Pfizer
DualityBio Inc.
SOFIE
Lumicell, Inc.
RemeGen Co., Ltd.
Anthos Therapeutics, Inc.
Hoffmann-La Roche
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
Shanghai Juncell Therapeutics
Société des Produits Nestlé (SPN)
DualityBio Inc.
GlaxoSmithKline
BicycleTx Limited
IDRx Inc. - A GSK Company
Elevation Oncology
Revolution Medicines, Inc.
BioMed Valley Discoveries, Inc
Bolt Biotherapeutics, Inc.
Jazz Pharmaceuticals
Arbele Limited
Revolution Medicines, Inc.
Pfizer
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Imugene Limited
Revolution Medicines, Inc.
Boehringer Ingelheim
Erasca, Inc.
Binhui Biopharmaceutical Co., Ltd.
Revolution Medicines, Inc.
GEM SRL
NantBioScience, Inc.
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Theseus Pharmaceuticals